Humana Inc. company logo

# 1st Gen Model Humana Inc. Hospital & medical service plans

68.42% successful of 76 deals
$253.64 Last close price
at 15-dec-2017


Model's trade recommendations 2.60% Return for period

2.24% Annual return

$36.61B Market Cap

β 0.88  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 2.60%
52wk return 5.48%
52wk Range
Sortino ratio 0.29
Sharpe ratio 0.23
Norm. RMSE 0.67%
Downside risk 8.58%
Volatility 10.76%
  • 1.60 (0.62%) Div (Yield)
  • BUY Analysts consensus recommendation

Humana Inc. is committed to helping their millions of medical and specialty members achieve their best health. Humana's successful history in care delivery and health plan administration is helping them create a new kind of integrated care with the power to improve health and well-being and lower costs. Its efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision etc. The Group segment offers commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits etc. The Healthcare Services segment offers pharmacy solutions, provider services, home based services, clinical programs etc.

Industry sector: Medical

Sector classification: Hospital & medical service plans

Deep Learning based analysis and prediction model for Humana Inc. (HUM) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for HUM model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 142M
P/E 21.86
Shares Outstanding 143M
% Held by Insiders 0.80%
% Held by Institutions 94.19%
EPS (last reported FY) $9.57
EPS (last reported Q) $3.39
EPS, estimated (last reported Q) $3.27
Total revenues $54 B
Net income $1 B